Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
See this aricle in Pubmed

Article Abstract
The PIs have emerged as critical drugs for people with HIV infection. Optimal sue involves combination with reverse transcriptase inhibitors. Resistance develops to each agent,and cross-resistance is likely.These agents must be used at full doses with attention to ensuring patient compliance.The expense of these agents may be offset by forestalling disease progression and death and returning people to productive life. Selecting the initial PI must be individualized,and factors to consider include proven activity,possible toxicities,dosing regimens,drug interactions,and costs.
 
Related Tags
(click to filter results - removes previous filter)

acquired immunodeficiency syndrome
antiviral agents
cost effectiveness
diarrhea
fatigue
headache
human immunodeficiency virus type 1
indinavir
life expectancy
nausea and vomiting
nelfinavir
pain,abdominal
paresthesias
paresthesias,circumoral
prognosis
protease inhibitor,HIV-1
ritonavir
saquinavir
taste
treatment of neurologic disorder

Click Here to return To Results